286 related articles for article (PubMed ID: 19715550)
1. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
Vestergaard M; Hamada T; Morita M; Takagi M
Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.
Gibson Wood W; Eckert GP; Igbavboa U; Müller WE
Biochim Biophys Acta; 2003 Mar; 1610(2):281-90. PubMed ID: 12648781
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
4. Role of amyloid beta in lipid homeostasis.
Grösgen S; Grimm MO; Friess P; Hartmann T
Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
[TBL] [Abstract][Full Text] [Related]
5. Neuronal membrane cholesterol loss enhances amyloid peptide generation.
Abad-Rodriguez J; Ledesma MD; Craessaerts K; Perga S; Medina M; Delacourte A; Dingwall C; De Strooper B; Dotti CG
J Cell Biol; 2004 Dec; 167(5):953-60. PubMed ID: 15583033
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Aβ metabolism.
Wang C; Shou Y; Pan J; Du Y; Liu C; Wang H
Nutr Neurosci; 2019 Jul; 22(7):453-463. PubMed ID: 29325505
[TBL] [Abstract][Full Text] [Related]
7. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: cholesterol a menace?
Mathew A; Yoshida Y; Maekawa T; Kumar DS
Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
[TBL] [Abstract][Full Text] [Related]
9. ABCA5 regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology.
Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
J Alzheimers Dis; 2015; 43(3):857-69. PubMed ID: 25125465
[TBL] [Abstract][Full Text] [Related]
10. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
12. Utilizing magnetic resonance techniques to study membrane interactions of amyloid peptides.
Rajput S; Sani MA; Keizer DW; Separovic F
Biochem Soc Trans; 2021 Jun; 49(3):1457-1465. PubMed ID: 34156433
[TBL] [Abstract][Full Text] [Related]
13. The role of cholesterol metabolism in Alzheimer's disease.
Sun JH; Yu JT; Tan L
Mol Neurobiol; 2015; 51(3):947-65. PubMed ID: 24838626
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and statins in Alzheimer's disease: current controversies.
Fonseca AC; Resende R; Oliveira CR; Pereira CM
Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
[TBL] [Abstract][Full Text] [Related]
15. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
[TBL] [Abstract][Full Text] [Related]
16. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
[TBL] [Abstract][Full Text] [Related]
17. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
18. Can statins put the brakes on Alzheimer's disease?
Whitfield JF
Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
[TBL] [Abstract][Full Text] [Related]
19. Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains.
Williamson R; Sutherland C
Curr Alzheimer Res; 2011 Mar; 8(2):213-21. PubMed ID: 21222605
[TBL] [Abstract][Full Text] [Related]
20. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation.
Lee SI; Jeong W; Lim H; Cho S; Lee H; Jang Y; Cho J; Bae S; Lin YT; Tsai LH; Moon DW; Seo J
Stem Cell Reports; 2021 Sep; 16(9):2128-2137. PubMed ID: 34450034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
